fnagi-11-00065 March21,2019 Time:16:26 #1
ORIGINALRESEARCH
published:22March2019
doi:10.3389/fnagi.2019.00065
Cognitive Performance Concomitant
With Vision Acuity Predicts 13-Year
Risk for Mortality
HuanLiao1,2†,ZhuotingZhu3*†,HongxuanWang1,2,XiaomingRong1,2,
CharlotteAimeeYoung4andYingPeng1,2*
1DepartmentofNeurology,SunYat-senMemorialHospital,SunYat-senUniversity,Guangzhou,China,2Guangdong
ProvincialKeyLaboratoryofMalignantTumorEpigeneticsandGeneRegulation,SunYat-senMemorialHospital,Sun
Yat-senUniversity,Guangzhou,China,3StateKeyLaboratoryofOphthalmology,ZhongshanOphthalmicCenter,Sun
Yat-senUniversity,Guangzhou,China,4DepartmentofOphthalmology,UniversityofCalifornia,SanFrancisco,
SanFrancisco,CA,UnitedStates
Objective: To assess the joint impact of cognitive performance and visual acuity on
mortalityover13-yearfollow-upinarepresentativeUSsample.
Methods: Data from National Health and Nutrition Examination Survey (NHANES)
participants(≥18yearsold)werelinkedwiththedeathrecorddataoftheNationalDeath
Index(NDI)withmortalityfollow-upthroughDecember31,2011.Cognitiveperformance
wasevaluatedbytheDigitSymbolSubstitutionTest(DSST)andcognitiveperformance
impairmentwasdefinedastheDSSTscoreequaltoorlessthanthemedianvalueinthe
study population. Visual impairment (VI) was defined as presenting visual acuity worse
than20/40inthebetter-seeingeye.Risksofall-causeandspecific-causemortalitywere
Editedby:
PatriziaMecocci, estimatedwithCoxproportionalhazardsmodelsafteradjustingforconfounders.
UniversityofPerugia,Italy
Results:Atotalof2,550participants60yearsandolderfromtwowavesof(NHANES,
Reviewedby:
YunhwanLee, 1999–2000, 2001–2002) were included in the current analysis. Over a median follow-
AjouUniversity,SouthKorea up period of 9.92 years, 952 (35.2%) died of all causes, of whom 239 (23.1%),
Bao-LiangZhong,
224 (24.0%), and 489 (52.9%) died from cardiovascular disease (CVD), cancer, and
WuhanMentalHealthCenter,China
non-CVD/non-cancer mortality, respectively. Cognitive performance impairment and VI
*Correspondence:
ZhuotingZhu increased the odds for mortality. Co-presence of VI among cognitive impaired elderly
zhuoting_zhu@hotmail.com
persons predicted nearly a threefold increased risk of all-cause mortality [hazard ratios
YingPeng
docpengy123@163.com; (HRs), 2.74; 95% confidence interval (CI), 2.02–3.70; P < 0.001) and almost a fourfold
pengy2@mail.sysu.edu.cn higherriskofnon-CVD/non-cancermortality(HR,3.72;95%CI,2.30–6.00;P<0.001)
†Theseauthorshavecontributed
comparedtohavingneitherimpairment.
equallytothiswork
Conclusion: People aged 60 years and over with poorer cognitive performance were
Received:13October2018
at higher risk of long-term mortality, and were especially vulnerable to further mortality
Accepted:06March2019
Published:22March2019 when concomitant with VI. It is informative for clinical implication in terms of early
Citation: preventiveinterventions.
LiaoH,ZhuZ,WangH,RongX,
YoungCAandPengY(2019) Keywords:cognitiveperformance,visionacuity,jointimpact,mortality,NHANES
CognitivePerformanceConcomitant
WithVisionAcuityPredicts13-Year
Abbreviations: BMI,bodymassindex;CIs,confidenceintervals;CRP,C-reactiveprotein;CVD,cardiovasculardisease;
RiskforMortality. DSST,DigitSymbolSubstitutionTest;HRs,hazardratios;ICD,InternationalClassificationofDiseases;NDI,NationalDeath
Front.AgingNeurosci.11:65. Index;NHANES,NationalHealthandNutritionExaminationSurvey;PIR,povertyincomeratio;SE,standarderrors;VI,
doi:10.3389/fnagi.2019.00065 visualimpairment.
FrontiersinAgingNeuroscience|www.frontiersin.org 1 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #2
Liaoetal. CognitionandVisionImpactMortality
INTRODUCTION every 2 years by Centers for Disease Control and Prevention
and National Center for Health Statistics (2005). Participants
Lifeexpectancyinindustrializedcountrieshasbeenprojectedto were recruited from the US non-institutionalized civilian
increasecontinuously,withmostoftheprojectedgainsoccurring populationusingstratifiedmultistagedesign,withoversampling
in older ages (Kontis et al., 2017). However, a non-negligible of certain subgroups1. Participants were invited to a mobile
disadvantage to gains in longevity is the increased risk of the examination center for an extensive examination that included
impairment of both vision and cognition with age. VI is highly physical examinations, laboratory tests, and questionnaires. All
prevalentamongagedpeople,notonlyleadingtomorbidity,but participantswereinformedaboutthestudyandgavetheirwritten
imposinganimpactontheriskofmortalityaswell(Zhangetal., consent prior to assessments. The study protocols and data
2016; Zhu et al., 2016). It has been estimated that the number collection were conducted according to ethical standards. The
ofvisuallyimpairedpeoplecoulddoubleby2050(Varmaetal., researchadheredtotheguidelinesoftheDeclarationofHelsinki.
2016).Theextendedlifeexpectancyandagingpopulation,rising
rapidlyaroundtheworld,havealsoledtoincreasingprevalence Assessment of Cognitive Performance
of dementia (Brookmeyer et al., 2007). Cognitive decline and TheDSSTwasincludedinthe1999–2002cyclesofNHANESto
impairment associated with age have also been proposed to be assess cognitive performance among participants aged 60 years
linked with an increased mortality (Sachs et al., 2011). Hence, and older. The DSST is a widely used test with high sensitivity
well-established identification and management on both visual for assessing sustained attention, psychomotor speed, and
andcognitiveimpairmentareparticularlycrucialforimproving workingmemoryinepidemiologicandneuropsychologicstudies
healthinlaterlives. (Wechsler, 2007). Based on codes, participants were required
Emerging evidence suggests a strong linkage between to pair the numbers (1–9) with corresponding symbols. The
impairment of vision and cognitive impairment (Rogers and total number of correctly matched symbols within 2 min
Langa, 2010; Elyashiv et al., 2014; Chen et al., 2017). It has was calculated for the DSST points (0–133). Higher correct
been proposed in large cohort studies that higher rates of scores represent better cognitive performance. Since there is
cognitive performance impairment exist among aged adults no gold standard cutoff for cognitive performance impairment
with VI (Elyashiv et al., 2014). In a prospective cohort study, based on the DSST score, we defined cognitive performance
VI has been demonstrated to predict cognitive decline (Lin impairmentasbelowthemedianDSSTscore(DSSTvalueof40),
etal.,2004).Furthermore,severalstudieshaveshownimproved consistent with methods previously described in other studies
cognitive performance scores by treating reduced vision via (Loprinzietal.,2017).
cataract surgery (Tamura et al., 2004; Ishii et al., 2008).
Alternatively, severe cognitive performance impairment may Assessment of Visual Acuity
raise the risk of incident functional VI, even though the eyes Presenting visual acuity was evaluated for each eye with
remain structurally healthy (Chen et al., 2017). Although VI participants’ usual distance vision correction with an
and cognitive performance impairment have been associated autorefractor (ARK-760, Nidek Co., Ltd.). Details of methods
with mortality separately as mentioned above, much less is for visual acuity measurement have been described elsewhere
known about the joint effects of cognitive impairment and VI (Ko et al., 2012). Presenting visual acuity worse than 20/40
on mortality. It has been reported that concomitant VI and in the better-seeing eye was used to define VI based on the
cognitive impairment increases mortality in a US study (Liu latest guidelines of the US Preventive Services Task Force
et al., 2016), while no relation was found in a Japanese study (Chouetal.,2016).
(Mitoku et al., 2016). Notably, in those two studies, VI was
assessedbyself-reportingandthegeneralizabilityofthestudies Mortality Data
are limited. Furthermore, those two studies did not explore the
Mortality data were obtained from the NDI through a
specific mortality associated with the joint effect of visual and
probabilistic matching algorithm (Loprinzi and Addoh, 2016).
cognitiveimpairment. Mortality for NHANES participants (≥18 years old) was
TheNHANESisacontinuouspopulation-basedstudy,which
followed-up through December 31, 2011. Participants were
provides an opportunity to investigate the impact of cognitive
considered alive when they could not be matched with NDI
performance concomitant with VI on mortality in a nationally
data. The specific cause of death was coded according to the
representative population of the non-institutionalized US civi-
tenth revision of ICD, Injuries and Causes of death (ICD-10).
lian. We hypothesize that not only does cognitive performance
ICD-10codesI00-I09,I11,I13,andI20-I51wereusedtodefine
impairment and VI independently predicts mortality, but the
thedeathfromheartdisease,andcodesI60-I69indicatedtothe
combinationofbothalsopredictsincreasemortality.
decease from cerebrovascular diseases. The combination codes
of deaths from heart disease and cerebrovascular diseases were
usedtorepresentdeathsfromCVD.ICD-10codesC00-C97were
MATERIALS AND METHODS
used to define cancer mortality. Those who were not classified
as CVD or cancer-related deaths were considered as death due
Sample and Population
to non-CVD/non-cancer cause. The follow-up period for each
This dataset was extracted from two cycles of NHANES
(1999–2000, 2001–2002), which is an ongoing study conducted 1http://www.cdc.gov/nchs/nhanes.htm
FrontiersinAgingNeuroscience|www.frontiersin.org 2 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #3
Liaoetal. CognitionandVisionImpactMortality
participantwascalculatedasthetimelengthfromthedateofthe marital status, and income status), and then additionally for
interviewtoeitherthedateofdeathorattheendofthefollow-up BMI, smoking status, drinking status, hypertension, diabetes
(December31,2011),whicheverhappenedfirst. mellitus, cholesterol level, CRP, history of CVD, and cancer.
We also evaluated the joint effect of cognitive performance
Covariates
impairment and VI on mortality by adjusting for multiple
Covariates were selected on the basis of established association covariates. To correct the estimates for non-response, inverse
in previous studies both with exposure (VI or cognitive probability weighting was used in the sensitivity analyses.
performance) and outcome (mortality) (Chen et al., 2017). All Sensitivity analyses were also performed after Markov chain
sociodemographic factors (age, gender, race, education level, Monte-Carlo imputations to address the missing data. The
maritalstatus,andPIR),health-relatedbehaviors(smokingstatus proportional-hazardsassumptionforeachvariablewastestedby
and alcohol consumption), and comorbid medical conditions generating time-dependent covariates, with P-value < 0.05 for
(BMI, diabetes, hypertension, high cholesterol, CRP level, the interaction of the variable and a function of survival time
history of CVD, and cancer) were assessed using self-reported regarded as violating the assumption. All variables were found
questionnairesorlaboratorytests. to be valid (P > 0.05). All data analyses were performed using
Ethnicity was classified as Non-Hispanic White, Non- STATA(ver.14.0;StataCorp.,CollegeStation,TX,UnitedStates).
Hispanic Black, Mexican American, and other. Education level Two-sided P-values less than 0.05 were considered to indicate
was classified as less than high school degree and equal to or statisticalsignificance.
more than high school diploma. Marital status (unmarried and
other, married/with a partner) was categorized as a two-level
covariate. PIR, the indicator of family income, was categorized RESULTS
as below poverty (<1.00) and at or above poverty (≥1.00).
Smokingstatuswasdefinedastwogroups:never,former/current Atotalof3,234participantsaged60yearsorolderparticipated
smoker.Alcoholconsumptionwasclassifiedaslifetimeabstainer in NHANES (1999/2002). Among these individuals, 684
or former drinker, current drinker with equal to or less than 3, were excluded because of missing information on DSST
andcurrentdrinkerwithmorethanthreedrinksperweek. score (522 participants) and missing data on visual acuity
Bodymassindexwascalculatedasweightinkilogramsdivided (162 participants), leading to a final analytical sample of 2,550
byheightinmeterssquared.Participantsweredefinedashaving participants. Compared with participants with complete data,
diabetesiftheyhadself-reportedphysiciandiagnosisofdiabetes, participants with incomplete data were older (P < 0.001),
glycosylated hemoglobin (%) levels of 6.5% or more, or used more likely to be non-Hispanic black (P < 0.001) and be
insulin or the prescription of diabetic agents (Varma et al., unhealthy regarding lifestyle and clinical measures. Other
2014).Thepresenceofhypertensionwasdefinedbyself-reported baseline characteristics of subjects excluded and included are
history of hypertension; or the use of antihypertensive agents; showninSupplementaryTableS1.Amongthe2,550participants
or mean systolic blood pressure ≥140 mm Hg; and/or mean included in the current analysis, the mean (SE) DSST score
diastolicbloodpressure≥90mmHgafterthreemeasurements. was 46.9 ± 0.60 points. Table 1 provides basic characteristics
Individualswereclassifiedashavinghighcholesterolwithserum of participants overall and by quartile of DSST score. The
totalcholesterol≥240mg/dLortheuseoflipid-loweringagent. mean (SE) age was 70.6 ± 0.29 years, 56.5% of participants
High level of CRP was defined as CRP 1 mg/dL or over. were women and 84.0% non-Hispanic white. Participants with
HistoryofCVDwasdefinedbyphysiciandiagnosisofcongestive a higher quartile of DSST score were more likely to have
heart failure, coronary heart disease, angina, heart attack, or better vision, be younger, non-Hispanic white people, well
stroke. History of cancer was based on a previous physician’s educated,marriedorwithpartner,higherincomeindex,current
diagnosisofcancer. drinker, and healthier in terms of diabetes, hypertension, and
history of CVD. There was no significant difference in other
Statistical Analysis characteristics within quartile of DSST score. Supplementary
We followed the standard NHANES analytic procedures for Table S2 illustrates demographic, health-related behaviors, and
weighting,takingthecomplex,stratifieddesignofNHANESinto general health characteristics among participants with and
account. Continuous data were presented as means and SEs, withoutVI.Olderage,non-whiteethnicity,lowereducationlevel,
and categorical variables were shown as numbers and weighted unmarriedstatus,lowerBMIvalue,hypertension,andhistoryof
percentages. We used the design-adjusted one-way analysis CVDorcancerweresignificantlyassociatedwithVI.
of variance and Rao–Scott Pearson χ2 for the comparison After a median follow-up period of 9.92 years, 952 (35.2%)
of continuous and categorical variables, respectively. Plots of deaths occurred. Of 952 deaths, 239 (23.1%), 224 (24.0%),
survival curves were generated using Kaplan–Meier estimates and 489 (52.9%) cases were attributed to CVD, cancer, and
and the log-rank test was used for comparing the survival non-CVD/non-cancer causes, respectively. The comparisons of
distributions among groups. The risks of mortality associated quartiles of DSST score, VI, and baseline characteristics by
with cognitive performance impairment or VI were estimated mortality status are shown in Table 2. All-cause mortality
using Cox proportional hazards regression models to estimate rates were higher for those participants with a lower quartile
HRs with 95% CIs. All models were first adjusted for age, of DSST score and those with VI. Age- and gender-adjusted
gender,ethnicity,andsociodemographicfactors(educationlevel, Coxproportionalhazardsregressionmodelsshowedcovariates,
FrontiersinAgingNeuroscience|www.frontiersin.org 3 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #4
Liaoetal. CognitionandVisionImpactMortality
TABLE1|Baselinecharacteristicsofparticipantsbydigit-symbolsubstitutiontestscorequintile.
Characteristics Overall(N=2,550) DSSTscorea Pb
Q1(n=591) Q2(n=630) Q3(n=644) Q4(n=685)
VI
No 2,278(91.6%) 471(78.3%) 545(88.3%) 600(93.9%) 662(97.3%) <0.001
Yes 272(8.4%) 120(21.7%) 85(11.7%) 44(6.1%) 23(2.7%)
Age(SE),years 70.6±0.29 74.5±0.64 72.7±0.36 71.0±0.36 67.4±0.26 <0.001
Gender
Male 1,257(43.5%) 312(42.8%) 337(48.0%) 325(45.3%) 283(39.7%) 0.098
Female 1,293(56.5%) 279(57.2%) 293(52.0%) 319(54.7%) 402(60.3%)
Race
Non-Hispanicwhite 1,543(84.0%) 197(61.0%) 365(81.1%) 433(86.6%) 548(92.9%) <0.001
Non-Hispanicblack 370(6.5%) 144(17.6%) 105(8.0%) 78(5.1%) 43(2.2%)
MexicanAmerican 487(2.7%) 198(7.2%) 123(3.0%) 100(2.1%) 66(1.1%)
Other 150(6.9%) 52(14.3%) 37(7.8%) 33(6.2%) 28(3.8%)
Education
Lessthanhighschool 1,000(29.0%) 448(67.0%) 302(43.0%) 170(21.9%) 80(10.5%) <0.001
Highschoolandover 1,549(71.0%) 142(33.0%) 328(57.0%) 474(78.1%) 605(89.5%)
Maritalstatus
Unmarriedandother 911(35.4%) 248(49.7%) 259(43.7%) 227(35.2%) 177(24.9%) <0.001
Married/withapartner 1,523(64.6%) 305(50.3%) 344(56.3%) 387(64.8%) 487(75.1%)
PIR
Belowpoverty(<1) 340(12.1%) 175(36.2%) 85(12.9%) 58(9.5%) 22(3.8%) <0.001
Atorabovepoverty(≥1) 1,926(87.9%) 341(63.8%) 492(87.2%) 521(90.5%) 572(96.2%)
Smokingstatus
Never 1,190(47.0%) 294(54.1%) 288(45.5%) 291(46.3%) 317(45.6%) 0.091
Former/current 1,355(53.0%) 296(45.9%) 341(54.5%) 352(53.7%) 366(54.4%)
Alcoholconsumption
Lifetimeabstainer/formerdrinker 803(32.7%) 232(44.9%) 220(38.8%) 188(32.1%) 163(24.5%) <0.001
Currentdrinker(≤3drinks/w) 1,253(48.9%) 285(46.7%) 306(47.4%) 316(50.7%) 346(49.3%)
Currentdrinker(>3drinks/w) 434(18.5%) 55(8.5%) 89(13.8%) 123(17.3%) 167(26.2%)
BMI(SE),kg/m2 28.2±0.14 27.9±0.40 27.9±0.24 28.4±0.25 28.4±0.21 0.412
Diabetesmellitus
No 1,955(82.4%) 398(73.3%) 462(77.5%) 513(83.2%) 582(88.3%) <0.001
Yes 526(17.6%) 172(26.7%) 150(22.5%) 110(16.8%) 94(11.7%)
Hypertension
No 833(34.2%) 167(26.8%) 189(30.7%) 209(31.8%) 268(41.1%) <0.001
Yes 1,659(65.8%) 403(73.2%) 428(69.3%) 421(68.2%) 407(58.9%)
Highcholesterol
No 1,463(57.6%) 353(60.9%) 361(56.7%) 364(56.5%) 385(57.5%) 0.656
Yes 978(42.4%) 199(39.1%) 246(43.3%) 253(43.5%) 280(42.5%)
HighCRP
No 2,141(88.0%) 469(83.2%) 538(88.0%) 545(88.6%) 589(89.5%) 0.093
Yes 286(12.0%) 81(16.8%) 65(12.0%) 67(11.4%) 73(10.5%)
HistoryofCVD
No 1,973(77.1%) 431(68.4%) 445(67.0%) 511(79.3%) 586(85.0%) <0.001
Yes 577(22.9%) 160(31.6%) 185(33.0%) 133(20.7%) 99(15.0%)
Historyofcancer
No 2,068(78.7%) 510(80.5%) 500(77.6%) 513(78.7%) 545(78.6%) 0.779
Yes 482(21.3%) 81(19.5%) 130(22.4%) 131(21.3%) 140(21.4%)
DSST, Digit-Symbol Substitution Test; VI, visual impairment; SE, standard error; BMI, body mass index. Boldface indicates statistical significance. All proportions,
means, and SE are weighted estimates of the US population characteristics, taking into account the complex sampling design of the NHANES. aQ1–Q4, first
quartile–fourthquartile.bAllP-valueswerecalculatedusingone-wayanalysisofvarianceforcontinuousvariablesandthedesign-adjustedRao–ScottPearsonχ2test
forcategoricalvariables.
FrontiersinAgingNeuroscience|www.frontiersin.org 4 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #5
Liaoetal. CognitionandVisionImpactMortality
TABLE2|All-causemortalitybybaselinecharacteristics. TABLE3|Coxproportionalhazardsmodelsforall-causeandspecific-cause
mortalitybyDigit-SymbolSubstitutionTestscoreorVIstatus.
Numberof
survived Numberof Model1a Model2b
subjects, diedsubjects, Unadjusted
Characteristics n=1,598(%) n=952(%) P HR(95%CI)a Status (HRand95%CI) (HRand95%CI)
DSSTscore Cognitiveimpairment,Presentvs.Absentc
Quartile4 546(45.4%) 139(19.3%) <0.001 Reference
All-causemortality 2.00(1.65–2.42) 1.99(1.60–2.47)
Quartile3 425(28.3%) 219(24.8%) 1.37(1.11–1.69)
Cardiovascularmortality 1.90(1.39–2.59) 1.72(1.18–2.51)
Quartile2 328(16.4%) 302(33.1%) 2.37(1.93–2.93)
Quartile1 299(10.0%) 292(22.8%) 2.37(1.91–2.94) Cancermortality 1.21(0.76–1.90) 1.38(0.78–2.45)
VI Non-cancer/non-cardiovascular 2.57(1.90–3.47) 2.44(1.70–3.49)
No 1,475(94.3%) 803(86.8%) <0.001 Reference mortality
Yes 123(5.7%) 149(13.2%) 1.43(1.18–1.73) VI,Presentvs.Absentc
Age(SE),years 68.4±0.23 74.7±0.32 <0.001 1.11(1.10–1.12)
All-causemortality 1.37(1.07–1.73) 1.51(1.16–1.96)
Gender
Male 729(41.2%) 528(47.7%) 0.025 Reference Cardiovascularmortality 1.36(0.87–2.11) 1.43(0.80–2.56)
Female 869(58.8%) 424(52.3%) 0.66(0.56–0.79) Cancermortality 0.86(0.46–1.61) 0.97(0.46–2.01)
Race Non-cancer/non-cardiovascular 1.57(1.09–2.24) 1.75(1.22–2.52)
Non-Hispanicwhite 885(82.2%) 658(87.2%) 0.007 Reference
mortality
Non-Hispanicblack 238(6.6%) 132(6.3%) 1.22(0.98–1.52)
MexicanAmerican 361(3.1%) 126(1.9%) 0.83(0.67–1.03) HR, hazard ratio; CI, confidence interval; DSST, Digit-Symbol Substitution Test;
Other 114(8.1%) 36(4.6%) 0.70(0.48–1.02) VI,visualimpairment.Boldfaceindicatesstatisticalsignificance.All-causemortality
Education wasassessedthroughDecember31,2011.aModel1:Adjustedforage,gender,
Lessthanhighschool 601(25.7%) 399(35.1%) <0.001 Reference race, education level, marital status, income status. bModel 2: Model 1 plus
Highschoolandover 997(74.3%) 552(64.9%) 0.77(0.66–0.89) additionaladjustmentsforBMI,smokingstatus,drinkingstatus,diabetesmellitus,
Maritalstatus hypertension, cholesterol level, CRP, history of CVD, and cancer. cCognitive
Unmarriedandother 507(30.4%) 404(44.7%) <0.001 Reference
impairmentdefinedasDSSTscore≤40(medianscoreinpopulation);VIdefined
aspresentingvisualacuityworsethan20/40.
Married/withapartner 1,025(69.6%) 498(55.3%) 0.71(0.59–0.85)
PIR
Belowpoverty(<1) 192(9.6%) 148(16.4%) 0.021 Reference
including age, gender, education level, marital status, family
Atorabovepoverty 1,216(90.4%) 710(83.6%) 0.67(0.49–0.93)
(≥1) income index, smoking status, diabetes, cholesterol level, CRP
Smokingstatus level, history of CVD, and cancer, were significantly associated
Never 787(50.2%) 403(41.0%) <0.001 Reference with risks of mortality. After adjusting for multiple variables,
Former/current 807(49.8%) 548(59.0%) 1.58(1.36–1.83)
the Cox models indicated that poorer survival from all-cause,
Alcoholconsumption
CVD, and non-CVD/non-cancer was associated with cognitive
Lifetime 503(32.4%) 300(33.2%) 0.130 Reference
abstainer/formerdrinker performanceimpairment(allcauseHR,1.99;95%CI,1.60–2.47;
Currentdrinker(≤3 771(47.8%) 482(50.9%) 1.11(0.91–1.35) CVD HR, 1.72; 95% CI, 1.18–2.51; and non-CVD/non-cancer
drinks/w)
Currentdrinker(>3 283(19.9%) 151(16.0%) 0.89(0.70–1.13) HR, 2.44; 95% CI, 1.70–3.49) (Table3). Similarly, VI predicted
drinks/w) increasedriskofmortalityduetoall-causeandnon-CVD/non-
BMI(SE),kg/m2 28.6±0.16 27.5±0.20 <0.001 1.00(0.99–1.01) cancer causes in the multifactorial Cox models (all cause HR,
Diabetesmellitus
1.51; 95% CI, 1.16–1.96; and non-CVD/non-cancer HR, 1.75;
No 1,247(84.1%) 708(79.2%) 0.015 Reference
95%CI,1.22–2.52).
Yes 316(15.9%) 210(20.8%) 1.39(1.15–1.69)
Hypertension Kaplan–Meier curves for all-cause and specific-cause
No 569(37.6%) 264(28.0%) <0.001 Reference mortality by cognitive performance impairment and
Yes 992(62.4%) 667(72.0%) 1.16(0.96–1.41) concomitant VI are shown in Figure 1. Interactions between
Highcholesterol
cognitive performance impairment and VI were assessed, and
No 900(55.5%) 563(61.3%) 0.022 Reference
no significant interaction was found. Table 4 summarizes
Yes 638(44.5%) 340(38.7%) 0.86(0.75–1.00)
HighCRP the stratified analysis regarding the dual impact of cognitive
No 1,370(89.5%) 771(85.4%) 0.003 Reference performance impairment with VI on mortality. Considering
Yes 161(10.5%) 125(14.6%) 1.54(1.33–1.79) participants with neither cognitive performance impairment
HistoryofCVD
nor VI as the reference group, risk of mortality was increased
No 1,333(83.0%) 640(66.1%) <0.001 Reference
among those with cognitive performance impairment but
Yes 265(17.0%) 312(33.9%) 1.61(1.33–1.96)
Historyofcancer without VI (all-cause HR, 1.92; 95% CI, 1.50–2.47; CVD HR,
No 1,361(82.2%) 707(72.3%) <0.001 Reference 1.87;95%CI,1.22–2.86;cancerHR,1.28;95%CI,0.71–2.30;and
Yes 237(17.8%) 245(27.7%) 1.30(1.08–1.57) non-CVD/non-cancer HR, 2.31; 95% CI, 1.57–3.39). However,
DSST,Digit-SymbolSubstitutionTest;VI,visualimpairment;SE,standarderror;
participantswithonlyVIdidnotshowhigherriskofmortality.
BMI,bodymassindex;CI,confidenceinterval;HR,hazardratio.Boldfaceindicates
statisticalsignificance.All-causemortalitywasassessedthroughDecember31, Co-presence of VI among cognitively impaired elderly people
2011.Allproportions,means,andSEsareweightedestimatesoftheUSpopulation further increased nearly threefold risk of all-cause mortality
characteristics,takingintoaccountthecomplexsamplingdesignoftheNHANES. (HR, 2.74; 95% CI, 2.02–3.70) and almost fourfold risk of non-
Unadjusted P-values were calculated using one-way analysis of variance for
continuous variables and the design-adjusted Rao–Scott Pearson χ2 test for CVD/non-cancer mortality (HR, 3.72; 95% CI, 2.30–6.00). We
categoricalvariables.aAdjustedforageandgender. observed similar results to those reported in the main analyses
FrontiersinAgingNeuroscience|www.frontiersin.org 5 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #6
Liaoetal. CognitionandVisionImpactMortality
FIGURE1|Kaplan-Meiercurveshowingall-causeandspecific-causemortalitybycognitiveimpairmentandconcomitantVI,usingthe1999–2002NHANES.
All-causeandspecific-causemortalitywereassessedthroughDecember31,2011.Comparedtohavingneitherimpairment,co-presenceofVIandcognitive
impairmentpredictedincreasedriskofall-causemortalityandnon-CVD/non-cancermortality(A,D),butsimilarriskofCVDandcancerrelatedmortality(B,C).
in sensitivity analyses using inverse probability weighting for Wang et al., 2001; Khanna et al., 2013; Ng et al., 2018). In a
non-response issue (Supplementary Tables S3, S4). After recent meta-analysis, containing 29 prospective cohort studies
imputations of missing values, we also obtained similar results with 269,839 participants and 67,061 deaths, VI was found to
(SupplementaryTablesS5,S6). besignificantlyassociatedwithanincreasedriskofmortalityin
participantsolderthan65years(Zhangetal.,2016).
In our study, we highlighted the finding that impaired
DISCUSSION cognitiveperformanceaccompaniedbyVIadditionallyincreased
theriskofmortalityinourstudy,whichwasinlinewithastudy
In a pooled analysis of two nationally representative samples conducted in United States (Liu et al., 2016). On the contrary,
(2,550 US subjects aged 60 years and over), we observed that in a Japanese study, the joint effect of visual and cognitive
both cognitive performance impairment and VI independently impairment did not increase the risk of mortality compared to
predicted poorer survival. Additionally, the co-presence of those without visual/hearing and cognitive impairment, while
VI among cognitive impaired elderly predicted higher risk a significant increase in risk of mortality was observed among
of all-cause mortality and of non-CVD/non-cancer mortality individuals with dual impairment (visual and hearing) and
comparedtohavingneitherimpairment. cognitiveimpairment(Mitokuetal.,2016).Takingintoaccount
Visualimpairmentasariskfactorforcognitiveperformance the inclusion of hearing status, self-reported visual function
(Lin et al., 2004; Fischer et al., 2016; Chen et al., 2017) in and ethnicity in the Japan study might explain the different
the literature was consistent with our result. In addition, the results. Of note, even though we observed the significant
finding that impaired cognitive performance was a significant association between VI and mortality, the association between
predictor of mortality was consistent with previous studies VI but no impaired cognitive performance and mortality
(DeweyandSaz, 2001;Pernaetal., 2015;Battyetal.,2016; Lee did not reach statistical significance. This might due to the
etal.,2018).Moreover,arecentsystematicliteraturereviewalso small number of participants in the VI but no impaired
supports our results (Dewey and Saz, 2001). In terms of VI, cognitive performance group (n = 67), which might reduce
our results and those from previous studies suggested that VI the efficiency of statistical analysis and limit the ability of
increased the risk of all-cause mortality (McCarty et al., 2001; detectingtheassociation.
FrontiersinAgingNeuroscience|www.frontiersin.org 6 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #7
Liaoetal. CognitionandVisionImpactMortality
TABLE4|Coxproportionalhazardsregressionmodelsofall-causeandspecificcausemortalitybycognitiveandvisualstatus.
Numberof Crudemortality
events ratea Model1b Model2c Pforinteractiond
All-causemortality
Cognitiveandvisualstatuse 0.735
NeitherCInorVI(n=1,262) 331 23.9% 1.00(reference) 1.00(reference)
CIonly(n=1,016) 472 51.8% 1.96(1.58–2.44) 1.92(1.50–2.47)
VIonly(n=67) 27 38.7% 1.22(0.72–2.08) 1.27(0.77–2.11)
BothCIandVI(n=205) 122 63.3% 2.40(1.83–3.16) 2.74(2.02–3.70)
Cardiovascularmortality
Cognitiveandvisualstatuse 0.073
NeitherCInorVI(n=1,262) 77 5.3% 1.00(reference) 1.00(reference)
CIonly(n=1,016) 123 12.7% 2.07(1.44–2.97) 1.87(1.22–2.86)
VIonly(n=67) 8 14.1% 2.35(1.09–5.05) 2.31(0.98–5.41)
BothCIandVI(n=205) 31 11.6% 1.90(1.11–3.25) 1.87(0.90–3.88)
Cancermortality
Cognitiveandvisualstatuse 0.069
NeitherCInorVI(n=1,262) 108 8.0% 1.00(reference) 1.00(reference)
CIonly(n=1,016) 90 9.3% 1.14(0.72–1.81) 1.28(0.71–2.30)
VIonly(n=67) 2 2.1% 0.29(0.06–1.36) 0.17(0.02–1.37)
BothCIandVI(n=205) 24 11.8% 1.26(0.57–2.80) 1.65(0.62–4.39)
Non-cardiovascularmortality
Cognitiveandvisualstatuse 0.728
NeitherCInorVI(n=1,262) 146 10.7% 1.00(reference) 1.00(reference)
CIonly(n=1,016) 259 29.9% 2.48(1.79–3.44) 2.31(1.57–3.39)
VIonly(n=67) 17 22.5% 1.26(0.54–2.93) 1.36(0.62–2.98)
BothCIandVI(n=205) 67 39.8% 3.39(2.22–5.17) 3.72(2.30–6.00)
CI,cognitiveimpairment;VI,visualimpairment.Boldfaceindicatesstatisticalsignificance.ValuesarenumberofHR(95%CI).All-causeandspecific-causemortalitywas
assessedthroughDecember31,2011.aAllproportionsareweightedestimatesoftheUSpopulationcharacteristics,takingintoaccountthecomplexsamplingdesign
oftheNHANES.bModel1:Adjustedforage,gender,race,educationlevel,maritalstatus,andincomestatus.cModel2:Model1plusadditionaladjustmentsforBMI,
smokingstatus,drinkingstatus,diabetesmellitus,hypertension,cholesterollevel,CRP,historyofCVD,andcancer.dInteractionbetweenCIandVI.eCIdefinedasDSST
score≤40(medianscoreinpopulation);VIdefinedaspresentingvisualacuityworsethan20/40.
Several possible reasons may account for the joint effect Gottesmanetal.,2014).Insomecases,cognitiveimpairmentis
of VI and cognitive performance impairment on mortality. amarkerforseriousvascularconditions,suchasatherosclerosis,
One possible explanation could be that the VI and cognitive cerebrovascular disease, and diastolic hypertension (Gale et al.,
impairment contributed additionally to higher possibility of 1996). Additionally, vision function has also been shown to be
disability (Whitson et al., 2007), which has a close relationship associatedwithcardiovascular-relatedconditionsorriskfactors
withmortality(Majeretal.,2011).VInotonlyincreasestherisks (Bergmanetal.,2004;Kleinetal.,2014).Theunderlyingvascular
of fractures, falls, and accidents, but also decreases functional dysfunction related to both cognitive and visual health may
independence and ability to perform basic and instrumental enhancemortalityrate.Furtherstudiesarewarrantedtoexplore
activities in daily life (Keller et al., 1999; DiNuzzo et al., otherpossibleexplanations.
2001), and so these factors could adversely affect mortality. Relevantpublichealthimplicationsemergeaccordingtoour
As well, increased risk of falls, accidents, and poor control findings. This could inform clinicians that VI and cognitive
of underlying diseases due to cognitive impairment could also performance impairment are likely to have co-occurrence in
reduce survival (Dewey and Saz, 2001; Lievre et al., 2008; the elderly and could potentially increase their risks of deaths.
Muir et al., 2012). Moreover, impaired cognitive performance Although these conditions are not life threatening, they are
can predict functional status (Kelman et al., 1994), particularly recognizedasmarkersfordisabilityandvulnerability.Therefore,
motorfunction,whichitselfisabletoaffectmortality(McGuire neuropsychological tests, combined with vision function tests,
et al., 2006). Another explanation could be underlying vascular could be utilized to perform early identification to maximize
diseases. In our analysis, both impaired cognitive performance the potential impact of preventive interventions. Furthermore,
and VI were associated with hypertension as well as history rehabilitation of VI in elders, especially among cognitively
of CVD, which were significantly related to death. A large impairedpersons,maypotentiallyimprovelong-termsurvival.
number of studies have described a significant relationship Ourstudyincludedstrengthssuchasalargepopulation-based
between cognitive impairment and CVD (Dregan et al., 2013; elderly cohort, relatively long follow-up duration, standardized
FrontiersinAgingNeuroscience|www.frontiersin.org 7 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #8
Liaoetal. CognitionandVisionImpactMortality
objective methods for assessing visual acuity and cognitive DATA AVAILABILITY
performance, access to a wide range of demographic
characteristics, health indicators, comorbidities, and access DataanalyzedincurrentstudywasfromNHANEShttp://www.
to death records. However, several limitations may limit the cdc.gov/nchs/nhanes.htm/.
interpretation of results. First of all, we could not exclude
the residual confounding variables, such as family functioning
(Yeh and Liu, 2003; Bambara et al., 2009), which may play ETHICS STATEMENT
a role affecting both VI and cognitive performance, although
many confounding factors have been adjusted for. In addition, This study was carried out in accordance with the
only baseline measurements of vision function and cognitive recommendations of the National Center for Health Statistics
performance were employed, and no subsequent functional research ethics review board with written informed consent
changes in vision and cognitive performance were examined. from all subjects. All subjects gave written informed consent
Future prospective studies are needed to understand the inaccordancewiththeDeclarationofHelsinki.Theprotocolwas
relationship between changes in cognitive or vision status and approved by the National Center for Health Statistics research
survivalovertime.Thirdly,participantsincludedinthepresent ethicsreviewboard.
analysis were younger and healthier regarding lifestyle and
clinical measures, which might bias the results. Nevertheless,
we used inverse probability weighting model to adjust for
AUTHOR CONTRIBUTIONS
non-response and observed similar results. The robustness of
our conclusions was again verified after multiple imputation
HL,ZZ,andYPstudyconceptanddesign.HLandZZacquisition
for missing data. Last but not least, cognitive function is a
ofdataanddraftingofthemanuscript.HL,ZZ,andXRanalysis
multidimensional construct that cannot be comprehensively
andinterpretationofdata.HL,ZZ,HW,XR,CYandYPcritical
evaluated with a single test. However, the DSST is generally
revisionofthemanuscriptforimportantintellectualcontentand
thought to be more sensitive than many other measures,
finalapprovaloftheversiontobepublished.
especially for milder cognitive impairment. Of note, the DSST
exercise relies on visual spatial skills. Although we could not
completelymitigatetheeffectofVIoncognitiveperformancein
FUNDING
the present analysis, the trained interviewer in the NHANES
provided safeguards to control this potential confounding
This study was supported by National Natural Science
effect, including asking participants wear reading glasses when
Foundation of China (Grant No. 81572481) to YP, the Key
necessary, excluding blind participants and those who were
Project of Product, Study and Research of Guangzhou city
unabletocompleteapracticesessionduetovisual,physical,or
(Grant No. 201508020058) to YP, International Collaboration
cognitive impairments (NHANES, 1999–2000). Further studies
Program of Universities in Guangdong Province (Grant No.
exploringjointeffectsofcognitivefunctionmeasuredbydifferent
2012gjhz001) to YP, National Natural Science Foundation
tests that are less vision-dependent and visual function on
of China (Grant No. 81502167) to XR, the Fund of
mortalityareneededtoverifytherobustnessofourresults.
Guangdong Science and Technology (No. 2014A020212090)
and National Natural Science Foundation of China (No.
CONCLUSION 81601042)toHW.
In conclusion, subjects aged 60 years and older with poorer
cognitive performance are at higher risk of decreased long- SUPPLEMENTARY MATERIAL
termsurvival,andareespeciallyvulnerabletofurthermortality
when VI is presented. This could inform clinicians that The Supplementary Material for this article can be found
early preventive interventions could be exercised to potentially online at: https://www.frontiersin.org/articles/10.3389/fnagi.
improvelong-termsurvival. 2019.00065/full#supplementary-material
REFERENCES of an urban Swedish population followed from 70 to 97 years of age. Acta
Ophthalmol.Scand.82,166–174.doi:10.1111/j.1600-0420.2004.00182.x
Bambara,J.K.,Wadley,V.,Owsley,C.,Martin,R.C.,Porter,C.,andDreer,L.E. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007).
(2009).Familyfunctioningandlowvision:asystematicreview.J.Vis.Impair. ForecastingtheglobalburdenofAlzheimer’sdisease.AlzheimersDement 3,
Blind.103,137–149.doi:10.1177/0145482X0910300303 186–191.doi:10.1016/j.jalz.2007.04.381
Batty,G.D.,Deary,I.J.,andZaninotto,P.(2016).Associationofcognitivefunction Centers for Disease Control and Prevention and National Center for Health
withcause-specificmortalityinmiddleandolderage:follow-upofparticipants Statistics (2005). National Health and Nutrition Examination Survey Data.
intheenglishlongitudinalstudyofageing.Am.J.Epidemiol.183,183–190. Hyattsville,MD:USDepartmentofHealthandHumanServices.
doi:10.1093/aje/kwv139 Chen,S.P.,Bhattacharya,J.,andPershing,S.(2017).Associationofvisionloss
Bergman,B.,Nilsson-Ehle,H.,andSjostrand,J.(2004).Ocularchanges,riskmar- withcognitioninolderadults.JAMAOphthalmol.135,963–970.doi:10.1001/
kersforeyedisordersandeffectsofcataractsurgeryinelderlypeople:astudy jamaophthalmol.2017.2838
FrontiersinAgingNeuroscience|www.frontiersin.org 8 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #9
Liaoetal. CognitionandVisionImpactMortality
Chou,R.,Dana,T.,Bougatsos,C.,Grusing,S.,andBlazina,I.(2016).Screeningfor Loprinzi,P.D.,andAddoh,O.(2016).Predictivevalidityoftheamericancollege
impairedvisualacuityinolderadults:updatedevidencereportandsystematic ofcardiology/americanheartassociationpooledcohortequationsinpredicting
review for the US preventive services task force. JAMA 315, 915–933. doi: all-causeandcardiovasculardisease-specificmortalityinanationalprospective
10.1001/jama.2016.0783 cohort study of adults in the United States. Mayo Clin. Proc. 91, 763–769.
Dewey,M.E.,andSaz,P.(2001).Dementia,cognitiveimpairmentandmortality doi:10.1016/j.mayocp.2016.03.019
inpersonsaged65andoverlivinginthecommunity:asystematicreviewofthe Loprinzi,P.D.,Crush,E.,andJoyner,C.(2017).Cardiovasculardiseasebiomarkers
literature.Int.J.Geriatr.Psychiatry16,751–761.doi:10.1002/gps.397 on cognitive function in older adults: joint effects of cardiovascular disease
DiNuzzo, A. R., Black, S. A., Lichtenstein, M. J., and Markides, K. S. biomarkers and cognitive function on mortality risk. Prev. Med. 94, 27–30.
(2001).Prevalence[correctionofprevalance]offunctionalblindness,visual doi:10.1016/j.ypmed.2016.11.011
impairment,andrelatedfunctionaldeficitsamongelderlyMexicanAmericans. Majer,I.M.,Nusselder,W.J.,Mackenbach,J.P.,Klijs,B.,andvanBaal,P.H.(2011).
J.Gerontol.ABiol.Sci.Med.Sci.56,M548–M551.doi:10.1093/gerona/56.9. Mortality risk associated with disability: a population-based record linkage
M548 study.Am.J.PublicHealth101,e9–e15.doi:10.2105/AJPH.2011.300361
Dregan,A.,Stewart,R.,andGulliford,M.C.(2013).Cardiovascularriskfactorsand McCarty,C.A.,Nanjan,M.B.,andTaylor,H.R.(2001).Visionimpairmentpredicts
cognitivedeclineinadultsaged50andover:apopulation-basedcohortstudy. 5yearmortality.Br.J.Ophthalmol.85,322–326.doi:10.1136/bjo.85.3.322
AgeAgeing42,338–345.doi:10.1093/ageing/afs166 McGuire, L. C., Ford, E. S., and Ajani, U. A. (2006). The impact of cognitive
Elyashiv,S.M.,Shabtai,E.L.,andBelkin,M.(2014).Correlationbetweenvisual functioningonmortalityandthedevelopmentoffunctionaldisabilityinolder
acuityandcognitivefunctions.Br.J.Ophthalmol.98,129–132.doi:10.1136/ adultswithdiabetes:thesecondlongitudinalstudyonaging.BMCGeriatr.6:8.
bjophthalmol-2013-304149 doi:10.1186/1471-2318-6-8
Fischer,M.E.,Cruickshanks,K.J.,Schubert,C.R.,Pinto,A.A.,Carlsson,C.M., Mitoku,K.,Masaki,N.,Ogata,Y.,andOkamoto,K.(2016).Visionandhearing
Klein,B.E.,etal.(2016).Age-relatedsensoryimpairmentsandriskofcognitive impairments, cognitive impairment and mortality among long-term care
impairment.J.Am.Geriatr.Soc.64,1981–1987.doi:10.1111/jgs.14308 recipients:apopulation-basedcohortstudy.BMCGeriatr.16:112.doi:10.1186/
Gale, C. R., Martyn, C. N., and Cooper, C. (1996). Cognitive impairment and s12877-016-0286-2
mortalityinacohortofelderlypeople.BMJ312,608–611.doi:10.1136/bmj. Muir,S.W.,Gopaul,K.,andMonteroOdasso,M.M.(2012).Theroleofcognitive
312.7031.608 impairment in fall risk among older adults: a systematic review and meta-
Gottesman,R.F.,Schneider,A.L.,Albert,M.,Alonso,A.,Bandeen-Roche,K., analysis.AgeAgeing41,299–308.doi:10.1093/ageing/afs012
Coker,L.,etal.(2014).Midlifehypertensionand20-yearcognitivechange:the Ng,S.K.,Kahawita,S.,Andrew,N.H.,Henderson,T.,Craig,J.E.,andLanders,J.
atherosclerosisriskincommunitiesneurocognitivestudy.JAMANeurol.71, (2018). Association of visual impairment and all-cause 10-year mortality
1218–1227.doi:10.1001/jamaneurol.2014.1646 amongindigenousaustralianindividualswithincentralaustralia:thecentral
Ishii,K.,Kabata,T.,andOshika,T.(2008).Theimpactofcataractsurgeryon australianocularhealthstudy.JAMAOphthalmol.136,534–537.doi:10.1001/
cognitiveimpairmentanddepressivementalstatusinelderlypatients.Am.J. jamaophthalmol.2017.6787
Ophthalmol.146,404–409.doi:10.1016/j.ajo.2008.05.014 NHANES (1999–2000). Data Documentation, Codebook, and Frequencies:
Keller,B.K.,Morton,J.L.,Thomas,V.S.,andPotter,J.F.(1999).Theeffectof CognitiveFunctioning(CFQ):Appendix1:NHANESDigitSymbolSubstitution
visualandhearingimpairmentsonfunctionalstatus.J.Am.Geriatr.Soc.47, Exercise (CFQ): Interviewer Instructions. Available at: https://wwwn.cdc.
1319–1325.doi:10.1111/j.1532-5415.1999.tb07432.x gov/Nchs/Nhanes/1999-2000/CFQ.htm#Appendix_1:__NHANES_DIGIT_
Kelman, H. R., Thomas, C., Kennedy, G. J., and Cheng, J. (1994). Cognitive SYMBOL_SUBSTITUTION_EXERCISE_(CFQ):_Interviewer_Instructions.
impairmentandmortalityinoldercommunityresidents.Am.J.PublicHealth AccessedFeb19,2019.
84,1255–1260.doi:10.2105/AJPH.84.8.1255 NHANES (2001–2002). Data Documentation, Codebook, and Frequencies:
Khanna,R.C.,Murthy,G.V.,Giridhar,P.,Krishnaiah,S.,Pant,H.B.,Palamaner CognitiveFunctioning(CFQ):Appendix1:NHANESDigitSymbolSubstitution
SubashShantha,G.,etal.(2013).Cataract,visualimpairmentandlong-term Exercise (CFQ): Interviewer Instructions.Availableat: https://wwwn.cdc.gov/
mortalityinaruralcohortinIndia:theAndhraPradesheyediseasestudy.PLoS Nchs/Nhanes/2001-2002/CFQ_B.htm#Appendix_1.AccessedFeb19,2019.
One8:e78002.doi:10.1371/journal.pone.0078002 Perna,L.,Wahl,H.W.,Mons,U.,Saum,K.U.,Holleczek,B.,andBrenner,H.
Klein,R.,Lee,K.E.,Gangnon,R.E.,andKlein,B.E.(2014).Relationofsmoking, (2015). Cognitiveimpairment, all-causeand cause-specificmortality among
drinking,andphysicalactivitytochangesinvisionovera20-yearperiod:the non-demented older adults. Age Ageing 44, 445–451. doi: 10.1093/ageing/
beaverdameyestudy.Ophthalmology121,1220–1228.doi:10.1016/j.ophtha. afu188
2014.01.003 Rogers,M.A.,andLanga,K.M.(2010).Untreatedpoorvision:acontributing
Ko,F.,Vitale,S.,Chou,C.F.,Cotch,M.F.,Saaddine,J.,andFriedman,D.S.(2012). factortolate-lifedementia.Am.J.Epidemiol.171,728–735.doi:10.1093/aje/
PrevalenceofnonrefractivevisualimpairmentinUSadultsandassociatedrisk kwp453
factors,1999-2002and2005-2008.JAMA308,2361–2368.doi:10.1001/jama. Sachs, G. A., Carter, R., Holtz, L. R., Smith, F., Stump, T. E., Tu, W., et al.
2012.85685 (2011).Cognitiveimpairment:anindependentpredictorofexcessmortality:
Kontis, V., Bennett, J. E., Mathers, C. D., Li, G., Foreman, K., and Ezzati, M. acohortstudy.Ann.Intern.Med.155,300–308.doi:10.7326/0003-4819-155-
(2017).Futurelifeexpectancyin35industrialisedcountries:projectionswitha 5-201109060-00007
bayesianmodelensemble.Lancet389,1323–1335.doi:10.1016/S0140-6736(16) Tamura, H., Tsukamoto, H., Mukai, S., Kato, T., Minamoto, A., Ohno, Y.,
32381-9 etal.(2004).Improvementincognitiveimpairmentaftercataractsurgeryin
Lee,Y.,Kim,J.,Chon,D.,Lee,K.E.,Kim,J.H.,Myeong,S.,etal.(2018).The elderly patients. J. Cataract. Refract. Surg. 30, 598–602. doi: 10.1016/j.jcrs.
effectsoffrailtyandcognitiveimpairmenton3-yearmortalityinolderadults. 2003.10.019
Maturitas107,50–55.doi:10.1016/j.maturitas.2017.10.006 Varma, R., Bressler, N. M., Doan, Q. V., Gleeson, M., Danese, M., Bower,
Lievre, A., Alley, D., and Crimmins, E. M. (2008). Educational differentials J. K., et al. (2014). Prevalence of and risk factors for diabetic macular
in life expectancy with cognitive impairment among the elderly in the edemaintheUnitedStates.JAMAOphthalmol.132,1334–1340.doi:10.1001/
United States. J. Aging Health 20, 456–477. doi: 10.1177/08982643083 jamaophthalmol.2014.2854
15857 Varma, R., Vajaranant, T. S., Burkemper, B., Wu, S., Torres, M., Hsu, C.,
Lin,M.Y.,Gutierrez,P.R.,Stone,K.L.,Yaffe,K.,Ensrud,K.E.,Fink,H.A., etal.(2016).Visualimpairmentandblindnessinadultsintheunitedstates:
etal.(2004).Visionimpairmentandcombinedvisionandhearingimpairment demographicandgeographicvariationsfrom2015to2050.JAMAOphthalmol.
predictcognitiveandfunctionaldeclineinolderwomen.J.Am.Geriatr.Soc.52, 134,802–809.doi:10.1001/jamaophthalmol.2016.1284
1996–2002.doi:10.1111/j.1532-5415.2004.52554.x Wang,J.J.,Mitchell,P.,Simpson,J.M.,Cumming,R.G.,andSmith,W.(2001).
Liu,P.L.,Cohen,H.J.,Fillenbaum,G.G.,Burchett,B.M.,andWhitson,H.E. Visualimpairment,age-relatedcataract,andmortality.Arch.Ophthalmol.119,
(2016). Association of co-existing impairments in cognition and self-rated 1186–1190.doi:10.1001/archopht.119.8.1186
visionandhearingwithhealthoutcomesinolderadults.Gerontol.Geriatr.Med. Wechsler,D.(2007).Wechsleradultintelligencescale-III(WAIS-III).NewYork:
2,1–9.doi:10.1177/2333721415623495 psychologicalcorporation;1997.Am.J.Epidemiol.165,344–350.
FrontiersinAgingNeuroscience|www.frontiersin.org 9 March2019|Volume11|Article65
fnagi-11-00065 March21,2019 Time:16:26 #10
Liaoetal. CognitionandVisionImpactMortality
Whitson,H.E.,Cousins,S.W.,Burchett,B.M.,Hybels,C.F.,Pieper,C.F.,and mortality: the liwan eye study. Invest. Ophthalmol. Vis. Sci. 57, 2290–2295.
Cohen,H.J.(2007).Thecombinedeffectofvisualimpairmentandcognitive doi:10.1167/iovs.15-17673
impairment on disability in older people. J. Am. Geriatr. Soc. 55, 885–891.
doi:10.1111/j.1532-5415.2007.01093.x Conflict of Interest Statement: The authors declare that the research was
Yeh, S. C., and Liu, Y. Y. (2003). Influence of social support on cognitive conductedintheabsenceofanycommercialorfinancialrelationshipsthatcould
function in the elderly. BMC Health Serv. Res. 3:9. doi: 10.1186/1472-69 beconstruedasapotentialconflictofinterest.
63-3-9
Zhang,T.,Jiang,W.,Song,X.,andZhang,D.(2016).Theassociationbetween Copyright©2019Liao,Zhu,Wang,Rong,YoungandPeng.Thisisanopen-access
visual impairment and the risk of mortality: a meta-analysis of prospective articledistributedunderthetermsoftheCreativeCommonsAttributionLicense
studies.J.Epidemiol.Commun.Health70,836–842.doi:10.1136/jech-2016- (CCBY).Theuse,distributionorreproductioninotherforumsispermitted,provided
207331 theoriginalauthor(s)andthecopyrightowner(s)arecreditedandthattheoriginal
Zhu,Z.,Wang,L.,Young,C.A.,Huang,S.,Chang,B.H.,andHe,M.(2016). publicationinthisjournaliscited,inaccordancewithacceptedacademicpractice.No
Cataract-relatedvisualimpairmentcorrectedbycataractsurgeryand10-year use,distributionorreproductionispermittedwhichdoesnotcomplywiththeseterms.
FrontiersinAgingNeuroscience|www.frontiersin.org 10 March2019|Volume11|Article65
